On February 20, 2019 Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, reported that it will participate in the following investor conferences in February and March (Press release, Audentes Therapeutics, FEB 20, 2019, View Source [SID1234533498]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

8th Annual SVB Leerink Global Healthcare Conference Natalie Holles, President and Chief Operating Officer Format: Fireside ChatThursday, February 28, 2019, at 9:30 am ETNew York, New York
Cowen 39th Annual Health Care Conference Matthew R. Patterson, Chairman and Chief Executive Officer Format: Corporate Presentation Tuesday, March 12, 2019, at 11:20 am ET Boston, Massachusetts
To access live webcasts of the fireside chat and presentation, please visit the Events & Presentations page within the Investors + Media section of the Audentes website. Following each conference, a replay of the live webcast will be available on the Audentes website for approximately 30 days.